Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(31)
Published: May 28, 2021
Abstract
Immunotherapy
that
can
activate
immunity
or
enhance
the
immunogenicity
of
tumors
has
emerged
as
one
most
effective
methods
for
cancer
therapy.
Nevertheless,
single‐mode
immunotherapy
is
still
confronted
with
several
critical
challenges,
such
low
immune
response,
tumor
infiltration,
and
complex
immunosuppression
microenvironment.
Recently,
combination
other
therapeutic
modalities
a
powerful
strategy
to
augment
outcome
in
fighting
against
cancer.
In
this
review,
recent
research
advances
chemotherapy,
phototherapy,
radiotherapy,
sonodynamic
therapy,
metabolic
microwave
thermotherapy
are
summarized.
Critical
challenges
future
direction
immunotherapy‐based
also
discussed.
Chemical Reviews,
Journal Year:
2021,
Volume and Issue:
121(4), P. 1981 - 2019
Published: Jan. 25, 2021
Since
the
first
connection
between
Fenton
chemistry
and
biomedicine,
numerous
studies
have
been
presented
in
this
field.
Comprehensive
presentation
of
guidance
from
a
summary
its
representative
applications
cancer
therapy
would
help
us
understand
promote
further
development
This
comprehensive
review
supplies
basic
information
regarding
chemistry,
including
reactions
Fenton-like
reactions.
Subsequently,
current
progress
is
discussed,
with
some
corresponding
examples
presented.
Furthermore,
strategies
for
optimizing
performance
chemodynamic
guided
by
are
highlighted.
Most
importantly,
future
perspectives
on
combination
biomedicine
or
wider
range
catalytic
approaches
We
hope
that
will
attract
positive
attention
materials
science,
fields
tighten
their
connections.
Advanced Materials,
Journal Year:
2020,
Volume and Issue:
33(4)
Published: Dec. 2, 2020
Abstract
The
past
decades
have
witnessed
hyperthermia
therapy
(HTT)
as
an
emerging
strategy
against
malignant
tumors.
Nanomaterial‐based
photothermal
(PTT)
and
magnetic
(MHT),
highly
effective
noninvasive
treatment
models,
offer
advantages
over
other
strategies
in
the
of
different
types
However,
both
PTT
MHT
cannot
completely
cure
cancer
due
to
recurrence
distal
metastasis.
In
recent
years,
immunotherapy
has
attracted
widespread
attention
owing
its
capability
activate
body's
own
natural
defense
identify,
attack,
eradicate
cells.
Significant
efforts
been
devoted
studying
activated
immune
responses
caused
by
hyperthermia‐ablated
this
article,
synergistic
mechanism
HTT
immunotherapy,
including
immunogenic
cell
death
reversal
immunosuppressive
tumor
microenvironment
is
discussed.
reports
combination
or
HTT‐based
multimodal
with
immunoadjuvant
exploitation,
checkpoint
blockade
therapy,
adoptive
cellular
are
summarized.
As
highlighted,
these
could
achieve
synergistically
enhanced
therapeutic
outcomes
primary
tumors
metastatic
lesions,
prevent
recurrence,
prolong
survival
period.
Finally,
current
challenges
prospective
developments
HTT‐synergized
also
reviewed.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(48)
Published: Sept. 27, 2021
Chemodynamic
therapy
(CDT)
uses
the
tumor
microenvironment-assisted
intratumoral
Fenton
reaction
for
generating
highly
toxic
hydroxyl
free
radicals
(•OH)
to
achieve
selective
treatment.
However,
limited
efficiency
restricts
therapeutic
efficacy
of
CDT.
Recent
years
have
witnessed
impressive
development
various
strategies
increase
reaction.
The
introduction
these
reinforcement
can
dramatically
improve
treatment
CDT
and
further
promote
enhanced
(ECDT)-based
multimodal
anticancer
treatments.
In
this
review,
authors
systematically
introduce
strategies,
from
their
basic
working
principles,
mechanisms
representative
clinical
applications.
Then,
ECDT-based
is
discussed,
including
how
integrate
emerging
accelerating
therapy,
as
well
synergistic
ECDT
other
methods.
Eventually,
future
direction
challenges
therapies
are
elaborated,
highlighting
key
scientific
problems
unsolved
technical
bottlenecks
facilitate
translation.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(5), P. 8039 - 8068
Published: May 11, 2021
Cancer
cells
frequently
exhibit
resistance
to
various
molecular
and
nanoscale
drugs,
which
inevitably
affects
the
drugs'
therapeutic
outcomes.
Overexpression
of
glutathione
(GSH)
has
been
observed
in
many
cancer
cells,
solid
evidence
corroborated
resulting
tumor
a
variety
anticancer
therapies,
suggesting
that
this
biochemical
characteristic
can
be
developed
as
potential
target
for
treatments.
The
single
treatment
GSH-depleting
agents
potentiate
responses
different
cell
death
stimuli;
therefore,
an
adjunctive
strategy,
GSH
depletion
is
usually
combined
with
mainstream
therapies
enhancing
Propelled
by
rapid
development
nanotechnology,
readily
constructed
into
nanomedicines,
have
shown
steep
rise
over
past
decade.
Here,
we
review
common
nanomedicines
widely
applied
synergistic
treatments
recent
years.
Some
current
challenges
future
perspectives
depletion-based
are
also
presented.
With
understanding
structure–property
relationship
action
mechanisms
these
biomaterials,
hope
nanotechnology
will
further
realize
more
effective
disease
even
achieve
successful
clinical
translations.
ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(9), P. 11017 - 11028
Published: Aug. 13, 2020
Although
ferroptosis
therapy
has
been
proven
to
be
a
promising
strategy
for
cancer
treatment,
its
efficacy
still
might
limited
by
insufficient
H2O2
supply
in
tumor
tissue.
Herein,
we
designed
cell
membrane-cloaked
cascade
nanoreactor
based
on
ferric
metal–organic
frameworks
(MOF)
and
glucose
oxidase
(GOx)
decoration
synergistic
ferroptosis–starvation
anticancer
therapy.
The
GOx
can
catalyze
generate
sufficient
therapy,
the
consumption
caused
utilized
as
another
attractive
treatment
called
starvation
When
reached
sites,
high
concentration
of
GSH
reduced
Fe3+
trigger
structure
collapse
MOF
release
Fe2+
catalyzed
oxidation
H2O2.
Then
Fenton
reaction
happened
between
produce
hydroxyl
radicals
(•OH)
promoted
With
these
reactions,
was
realized.
Furthermore,
membrane
endows
homologous
targeting
immune
escaping
ability,
which
facilitated
accumulate
into
site
with
efficiency.
exhibits
efficiency
suppression
situ
consumed
produced
compounds,
promote
development
precise
cooperative
spatiotemporal
controllability.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(4)
Published: Oct. 26, 2021
At
present,
some
progress
has
been
made
in
the
field
of
cancer
theranostics
based
on
nanocatalysts
(NCs),
but
achieving
precise
response
to
specific
tumor
microenvironment
(TME)
remains
a
major
challenge.
Herein,
TME-responsive
upconversion
nanoparticles
(UCNPs)-based
smart
UCNPs@Cu-Cys-GOx
(UCCG)
nanosystem
is
engineered,
which
combines
natural
enzymes
and
nanozymes
so
as
amplify
reactive
oxygen
species
(ROS)
generation
situ
for
starvation/chemodynamic/immunotherapy.
One
biggest
merits
this
material
that
it
can
be
preserved
inert
(off)
normal
tissues,
only
TME
specifically
activated
(on)
through
series
enzymatic
cascades
boost
ROS
production
via
strategy
open
source
(H2
O2
self-supplying
ability)
reduce
expenditure
(glutathione
(GSH)
consuming
ability).
More
importantly,
enhanced
oxidative
stress
by
UCCG
NCs
reverses
immunosuppressive
TME,
facilitates
antitumor
immune
responses.
Meanwhile,
starvation/chemodynamic
synergistic
therapy
triggered
combined
with
PD-L1
antibody
effectively
inhibits
growth
primary
tumors
metastasis.
In
addition,
UCNPs
present
luminescence
enhancement,
exploited
visualize
reinforced
real
time.
Collectively,
work
provides
an
original
method
devising
exploitation
UCNPs-based
catalytic
immunotherapy.
Nanomedicine,
Journal Year:
2022,
Volume and Issue:
17(5), P. 303 - 324
Published: Jan. 21, 2022
Recent
studies
found
that
unbalanced
copper
homeostasis
affect
tumor
growth,
causing
irreversible
damage.
Copper
can
induce
multiple
forms
of
cell
death,
including
apoptosis
and
autophagy,
through
various
mechanisms,
reactive
oxygen
species
accumulation,
proteasome
inhibition,
antiangiogenesis.
Hence,
in
vivo
has
attracted
tremendous
attention
is
the
research
spotlight
field
treatment.
This
review
first
highlights
three
typical
copper's
antitumor
mechanisms.
Then,
development
diverse
biomaterials
nanotechnology
allowing
to
be
fabricated
into
structures
realize
its
theragnostic
action
discussed.
Novel
complexes
their
clinical
applications
are
subsequently
described.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(7)
Published: Dec. 22, 2021
Second
near-infrared
(NIR-II)
window
type-I
photosensitizers
have
intrinsic
advantages
in
photodynamic/photothermal
therapy
(PDT/PTT)
of
some
malignant
tumors
with
deep
infiltration,
large
size,
complicated
location,
and
low
possibility
surgery/radiotherapy.
Herein,
three
chalcogen-element-based
donor-acceptor-type
semiconducting
polymers
(poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4″H)-dione)-alt-2,5-(thiophene)]
(PTS),
poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4″H)-dione)-alt-2,5-(selenophene)]
(PTSe),
poly[2,2″-((E)-4,4″-bis(2-octyldodecyl)-[6,6″-bithieno[3,2-b]pyrrolylidene]-5,5″(4H,4'H)-dione)-alt-2,5-(tellurophene)]
(PTTe))
are
synthesized
fully
characterized,
demonstrating
strong
absorption
the
NIR-II
region.
Upon
adjusting
chalcogen
elements,
intramolecular
charge-transfer
characteristics
heavy-atom
effect
tuned
to
enhance
intersystem
crossing
rate,
improving
photodynamic
effect.
Moreover,
energy
levels
Gibbs
free
energies
facilitate
process.
As
a
result,
PTTe
nanoparticles
(NPs)
produce
superoxide
anion
radicals
(O2•-
)
more
efficiently
demonstrate
higher
photothermal
conversion
efficiency
than
PTS
PTSe
NPs
upon
(1064
nm)
laser
irradiation,
exhibiting
unprecedented
PDT/PTT
performance
vitro
vivo.
This
work
provides
ideas
for
achieving
high-performance
hypoxic
oncotherapy.